A review of Gaucher disease pathophysiology, clinical presentation and treatments

J Stirnemann, N Belmatoug, F Camou… - International journal of …, 2017 - mdpi.com
Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. It is
caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an …

Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?

A Oueslati - Journal of Parkinson's disease, 2016 - content.iospress.com
Abnormal accumulation of proteinaceous intraneuronal inclusions called Lewy bodies (LBs)
is the neurpathological hallmark of Parkinson's disease (PD) and related synucleinopathies …

Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial

S Mullin, L Smith, K Lee, G D'Souza… - JAMA …, 2020 - jamanetwork.com
Importance Mutations of the glucocerebrosidase gene, GBA1 (OMIM606463), are the most
important risk factor for Parkinson disease (PD). In vitro and in vivo studies have reported …

Dopamine, oxidative stress and protein–quinone modifications in Parkinson's and other neurodegenerative diseases

E Monzani, S Nicolis, S Dell'Acqua… - Angewandte Chemie …, 2019 - Wiley Online Library
Dopamine (DA) is the most important catecholamine in the brain, as it is the most abundant
and the precursor of other neurotransmitters. Degeneration of nigrostriatal neurons of …

The link between the GBA gene and parkinsonism

E Sidransky, G Lopez - The Lancet Neurology, 2012 - thelancet.com
Mutations in the glucocerebrosidase (GBA) gene, which encodes the lysosomal enzyme that
is deficient in Gaucher's disease, are important and common risk factors for Parkinson's …

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease

KE Murphy, AM Gysbers, SK Abbott, N Tayebi, WS Kim… - Brain, 2014 - academic.oup.com
Heterozygous mutations in GBA1, the gene encoding lysosomal glucocerebrosidase, are
the most frequent known genetic risk factor for Parkinson's disease. Reduced …

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

ME Gegg, D Burke, SJR Heales, JM Cooper… - Annals of …, 2012 - Wiley Online Library
Objective: Mutations in the glucocerebrosidase gene (GBA) represent a significant risk factor
for developing Parkinson disease (PD). We investigated the enzymatic activity of …

Autophagy and A lpha‐S ynuclein: R elevance to P arkinson's D isease and R elated S ynucleopathies

M Xilouri, OR Brekk, L Stefanis - Movement Disorders, 2016 - Wiley Online Library
Evidence from human postmortem material, transgenic mice, and cellular/animal models of
PD link alpha‐synuclein accumulation to alterations in the autophagy lysosomal pathway …

Glucocerebrosidase and its relevance to Parkinson disease

J Do, C McKinney, P Sharma, E Sidransky - Molecular neurodegeneration, 2019 - Springer
Mutations in GBA1, the gene encoding the lysosomal enzyme glucocerebrosidase, are
among the most common known genetic risk factors for the development of Parkinson …

Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated Parkinson's disease

YV Taguchi, J Liu, J Ruan, J Pacheco… - Journal of …, 2017 - Soc Neuroscience
Glucocerebrosidase 1 (GBA) mutations responsible for Gaucher disease (GD) are the most
common genetic risk factor for Parkinson's disease (PD). Although the genetic link between …